Compounds > n-palmitoylsphingosine

n-palmitoylsphingosine and 2019 Novel Coronavirus Disease

n-palmitoylsphingosine has been researched along with 2019 Novel Coronavirus Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Arap, W; Brinker, CJ; Brinker, LM; Canals, D; Cardó-Vila, M; Cristini, V; Dogra, P; Driessen, WHP; Ganju, A; Gelovani, JG; Giordano, RJ; Hannun, YA; Kolesnick, RN; Noureddine, A; Obeid, LM; Ozawa, MG; Pasqualini, R; Petrache, I; Proneth, B; Rotolo, JA; Schiavone, C; Smith, TL; Snider, AJ; Souza, GR; Staquicini, DI; Staquicini, FI; Tang, FHF; Tuder, RM; Wang, Z1

Other Studies

1 other study(ies) available for n-palmitoylsphingosine and 2019 Novel Coronavirus Disease

ArticleYear
Ceramide as an endothelial cell surface receptor and a lung-specific lipid vascular target for circulating ligands.
    Proceedings of the National Academy of Sciences of the United States of America, 2023, 08-22, Volume: 120, Issue:34

    Topics: Carrier Proteins; Ceramides; COVID-19; Endothelium, Vascular; Humans; Ligands; Lung; Receptors, Cell Surface; Sphingomyelin Phosphodiesterase

2023